PET and restaging of malignant lymphoma including residual masses and relapse-Reference-Cited by-同舟云学术

PET and restaging of malignant lymphoma including residual masses and relapse

Published:2003-05-14 Issue:S1 Volume:30 Page:S89-S96
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Reske S. N.

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-003-1167-4.pdf

Reference25 articles.

1. Dalla-Favera R, Gaidano GL. Lymphomas. In: De Vita VT, Rontrey SA, eds. Cancer, principles of oncology. Philadelphia: Lippincott Williams and Wilkins; 2001:2215–2387.

2. Aisenberg A. Problems in Hodgkin's disease management. Blood 1999; 93:761–779.

3. Reiser M, Diehl V. Current treatment of follicular non-Hodgkin's lymphoma. Eur J Cancer 2002; 38:1167–1172.

4. Canellos GP. Residual mass in lymphoma may not be residual disease. J Clin Oncol 1988; 6:931–933.

5. Lowe V, Wiseman GA. Assessment of lymphoma therapy using18F-FDG PET. J Nucl Med 2002; 43:1028–1030.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thoracic Imaging Manifestations of Treated Lymphomas;Journal of Thoracic Imaging;2022-01-13

2. Molecular and Functional Imaging in Oncology Therapy Response;Therapy Response Imaging in Oncology;2020

3. Stellenwert der Abdomensonografie in der Hämatologie;Zeitschrift für Gastroenterologie;2018-09

4. Diagnostic accuracy and interobserver agreement of contrast-enhanced ultrasound in the evaluation of residual lesions after treatment for malignant lymphoma and testicular cancer: a retrospective pilot study in 52 patients;Leukemia & Lymphoma;2018-02-27

5. Clinical Applications of PET/CT in Oncology;Basic Science of PET Imaging;2016-11-08